Starling Oncology, Inc. (STLNW) Total assets 2020–2025
Starling Oncology, Inc. (STLNW) total assets at each fiscal year-end, per SEC filings.
$164.7MFY2025 · since FY2020: $65.7M → $164.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $164.7M | -4.7% |
| FY2024 | $172.7M | -17.5% |
| FY2023 | $209.2M | -20.0% |
| FY2022 | $261.7M | +28.6% |
| FY2021 | $203.4M | +209.7% |
| FY2020 | $65.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More STLNW financial trends
STLNW RevenueSTLNW Net incomeSTLNW Net marginSTLNW Gross profitSTLNW Gross marginSTLNW Operating incomeSTLNW Operating marginSTLNW Operating cash flowSTLNW Free cash flowSTLNW Capital expendituresSTLNW Return on equitySTLNW Stock buybacksSTLNW Dividends paidSTLNW Total liabilitiesSTLNW Shareholders’ equitySTLNW overview →